Quick Guide: FDA Breast Density Notification

Understanding the FDA’s breast density notification requirement

Description

This resource explains the FDA’s updated MQSA requirement for breast density notification and how it affects both patient and provider communication.

What the MQSA update means for reporting and communication

This brochure outlines:

  • Required patient language
  • BI‑RADS density categories used in reports
  • Why getting the distinction between non‑dense and dense tissue right matters

It also reflects how software like Volpara® Scorecard™ can support imaging teams in complying with the requirements.

Download Now